This inventor holds 1 USPTO granted patent. Top assignee: Modernatx, Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Annika Pålsson: Innovator in Lipid Nanoparticle Technology
Introduction
Annika Pålsson is a prominent inventor based in Mölndal, Sweden. She has made significant contributions to the field of biotechnology, particularly in the development of lipid nanoparticles for medical applications. Her innovative work focuses on enhancing wound healing through advanced delivery systems.
Latest Patents
Annika holds a patent for "Lipid nanoparticles for delivering modified RNA encoding a VEGF-A polypeptide." This patent describes nanoparticles that comprise a lipid component and a modified RNA encoding a VEGF-A polypeptide. The technology aims to improve wound healing in subjects, showcasing the potential of lipid nanoparticles in therapeutic applications.
Career Highlights
Annika Pålsson is associated with Modernatx, Inc., where she continues to advance her research and development efforts. Her work is pivotal in the intersection of biotechnology and medicine, contributing to innovative solutions for health challenges.
Collaborations
Some of her notable coworkers include Kenny Mikael Hansson and Kerry Benenato, who collaborate with her on various projects within the company.
Conclusion
Annika Pålsson's contributions to lipid nanoparticle technology represent a significant advancement in the field of biotechnology. Her innovative approach to improving wound healing through modified RNA delivery systems highlights the importance of research in medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile